Eywa

Eywa Biotech is at the cutting edge of mental health innovation. Dedicated to developing psychedelic compounds through a decentralized, accessible platform using sustainable processes. This approach empowers laboratories and research centers to conduct clinical studies, aiming to evaluate the efficacy of these compounds in providing more effective and long-lasting treatments. Eywa Biotech is leading the way in reshaping mental health care by empowering research that aims to deliver transformative, long-lasting solutions.
Year
2024
Industry
Health Tech
Stage
Early
  • CEO
    Victoria Costa Paz
  • CSO
    Paola Rodríguez